Selectins impair regulatory T cell function and contribute to systemic lupus erythematosus pathogenesis.

Saved in:

Bibliographic Details
Title:	Selectins impair regulatory T cell function and contribute to systemic lupus erythematosus pathogenesis.
Authors:	Scherlinger M; Department of Rheumatology, Pellegrin, Bordeaux University Hospital, 33076 Bordeaux, France.; Centre national de référence maladie auto-immune et systémique rares Est/Sud-Ouest (RESO), Bordeaux University Hospital, 33076 Bordeaux, France.; UMR-CNRS 5164, ImmunoConcept, University of Bordeaux, 33076 Bordeaux, France., Guillotin V; Centre national de référence maladie auto-immune et systémique rares Est/Sud-Ouest (RESO), Bordeaux University Hospital, 33076 Bordeaux, France.; UMR-CNRS 5164, ImmunoConcept, University of Bordeaux, 33076 Bordeaux, France.; Department of Internal Medicine, Saint André, Bordeaux University Hospital, 33076 Bordeaux, France., Douchet I; UMR-CNRS 5164, ImmunoConcept, University of Bordeaux, 33076 Bordeaux, France., Vacher P; INSERM U1218, 33076 Bordeaux, France., Boizard-Moracchini A; UMR-CNRS 5164, ImmunoConcept, University of Bordeaux, 33076 Bordeaux, France., Guegan JP; Explicyte, 229 Cours de l'Argonne, 33000 Bordeaux, France., Garreau A; UMR-CNRS 5164, ImmunoConcept, University of Bordeaux, 33076 Bordeaux, France., Merillon N; UMR-CNRS 5164, ImmunoConcept, University of Bordeaux, 33076 Bordeaux, France., Vermorel A; Nephrology Department, Bordeaux University Hospital, 33076 Bordeaux, France., Ribeiro E; Department of Internal Medicine, Saint André, Bordeaux University Hospital, 33076 Bordeaux, France., Machelart I; Centre national de référence maladie auto-immune et systémique rares Est/Sud-Ouest (RESO), Bordeaux University Hospital, 33076 Bordeaux, France.; Department of Internal Medicine, Haut-Leveque, Bordeaux University Hospital, 33604, Pessac, France., Lazaro E; Centre national de référence maladie auto-immune et systémique rares Est/Sud-Ouest (RESO), Bordeaux University Hospital, 33076 Bordeaux, France.; Department of Internal Medicine, Haut-Leveque, Bordeaux University Hospital, 33604, Pessac, France., Couzi L; Nephrology Department, Bordeaux University Hospital, 33076 Bordeaux, France., Duffau P; Department of Internal Medicine, Saint André, Bordeaux University Hospital, 33076 Bordeaux, France., Barnetche T; Department of Rheumatology, Pellegrin, Bordeaux University Hospital, 33076 Bordeaux, France.; Centre national de référence maladie auto-immune et systémique rares Est/Sud-Ouest (RESO), Bordeaux University Hospital, 33076 Bordeaux, France., Pellegrin JL; Centre national de référence maladie auto-immune et systémique rares Est/Sud-Ouest (RESO), Bordeaux University Hospital, 33076 Bordeaux, France.; Department of Internal Medicine, Haut-Leveque, Bordeaux University Hospital, 33604, Pessac, France., Viallard JF; Centre national de référence maladie auto-immune et systémique rares Est/Sud-Ouest (RESO), Bordeaux University Hospital, 33076 Bordeaux, France.; Department of Internal Medicine, Haut-Leveque, Bordeaux University Hospital, 33604, Pessac, France., Saleh M; UMR-CNRS 5164, ImmunoConcept, University of Bordeaux, 33076 Bordeaux, France., Schaeverbeke T; Department of Rheumatology, Pellegrin, Bordeaux University Hospital, 33076 Bordeaux, France.; Centre national de référence maladie auto-immune et systémique rares Est/Sud-Ouest (RESO), Bordeaux University Hospital, 33076 Bordeaux, France., Legembre P; Contrôle de la Réponse Immune B et lymphoproliférations, CRIBL, UMR CNRS 7276, INSERM 1262, Limoges, France., Truchetet ME; Department of Rheumatology, Pellegrin, Bordeaux University Hospital, 33076 Bordeaux, France.; Centre national de référence maladie auto-immune et systémique rares Est/Sud-Ouest (RESO), Bordeaux University Hospital, 33076 Bordeaux, France.; UMR-CNRS 5164, ImmunoConcept, University of Bordeaux, 33076 Bordeaux, France., Dumortier H; CNRS, UPR 3572 I2CT, IBMC, 67000 Strasbourg, France., Contin-Bordes C; UMR-CNRS 5164, ImmunoConcept, University of Bordeaux, 33076 Bordeaux, France.; Department of Immunology and Immunogenetics, Bordeaux University Hospital, 33076 Bordeaux, France., Sisirak V; UMR-CNRS 5164, ImmunoConcept, University of Bordeaux, 33076 Bordeaux, France., Richez C; Department of Rheumatology, Pellegrin, Bordeaux University Hospital, 33076 Bordeaux, France. patrick.blanco@chu-bordeaux.fr christophe.richez@chu-bordeaux.fr.; Centre national de référence maladie auto-immune et systémique rares Est/Sud-Ouest (RESO), Bordeaux University Hospital, 33076 Bordeaux, France.; UMR-CNRS 5164, ImmunoConcept, University of Bordeaux, 33076 Bordeaux, France., Blanco P; Centre national de référence maladie auto-immune et systémique rares Est/Sud-Ouest (RESO), Bordeaux University Hospital, 33076 Bordeaux, France. patrick.blanco@chu-bordeaux.fr christophe.richez@chu-bordeaux.fr.; UMR-CNRS 5164, ImmunoConcept, University of Bordeaux, 33076 Bordeaux, France.; Department of Immunology and Immunogenetics, Bordeaux University Hospital, 33076 Bordeaux, France.
Source:	Science translational medicine [Sci Transl Med] 2021 Jun 30; Vol. 13 (600).
Publication Type:	Journal Article; Research Support, Non-U.S. Gov't
Journal Info:	Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1946-6242
DOI:	10.1126/scitranslmed.abi4994